Role of a responsive sympathetic nervous system in the chronic hypotensive effects of losartan in normal rats

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 2, 2005, Pages 147-154

  Collister, John P ^a   Osborn, John W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arterial pressure; Autonomic nervous Sytem; Ganglionic blockade; Hexamethonium

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN ANTAGONIST; HEXAMETHONIUM; LOSARTAN; PHENYLEPHRINE; SODIUM;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GANGLION BLOCK; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM RESTRICTION; SYMPATHETIC TONE; TELEMETRY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CHRONIC DISEASE; GANGLIONIC BLOCKERS; HEXAMETHONIUM; HYPOTENSION; LOSARTAN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 23044453462     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000167014.84715.6e     Document Type: Article

References (35)

1. Bunkenburg B, Schnell C, Baum H-P, et al. Prolonged angiotensin II antagonism in spontaneously hypertensive rats: hemodynamic and biochemical consequences. Hypertension. 1991;18:278-288.
2. Matsukawa T, Mano T, Gotoh E, et al. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest. 1993;92: 25-28.
3. Sweet C, Blaine E. Angiotensin converting enzyme inhibitors. In van Zwieten PA, ed: Handbook of Hypertension, Vol 3: Pharmacology of Antihypertensive Drugs. Amsterdam: Elsevier Science Publishing. 1984: 343-363.
4. Collister JP, Hornfeldt BJ, Osborn JW. Hypotensive response to losartan in normal rats: Role of ang II and the area postrema. Hypertension. 1996;27: 598-606.
5. Brown AJ, Casals-Stenzel J, Gifford J, et al. Comparison of fast and slow presser effects of angiotensin II in the conscious rat. Am J Physiol. 1981; 241:H381-H388.
6. DiBona GF, Jones SY, Sawin LL. Effect of endogenous angiotensin II on renal nerve activity and its arterial baroreflex regulation. Am J Physiol. 1996;271:R361-R367.
7. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanism and blood pressure regulation. Am J Physiol. 1986;250:R960-R972.
8. Krieger JE, Cowley AW Jr. Prevention of salt angiotensin II hypertension by servo control of body water. Am J Physiol. 1990;258:H994-H1002.
9. Reid IA. Interactions between Ang II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992; 262:E763-E778.
10. Griffin SA, Brown WCB, MacPherson F, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17:626-635.
11. Gorbea-Oppliger VJ, Melaragno MG, Potter GS, et al. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast presser effects. J Pharmacol Exp Ther. 1994;271:804-810.
12. Bickerton RK, Buckley JP. Evidence for a central mechanism in angiotensin induced hyptertension. Proc Soc Exp Biol Med. 1961;106: 834-836.
13. Yu R, Dickinson C. Neurogenic effects of angiotensin. Lancet. 1965;2: 1276-1277.
14. Li Q, Dale W, Hasser EM, et al. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am J Physiol. 1997;271 :R200-R207.
15. Bishop VS, Hay M. Involvement of the area postrema in the regulation of sympathetic outflow to the cardiovascular system. Frontiers Neuroendocrinol. 1993;14:57-75.
16. Brooks VL, Osborn JW. Hormonal-sympathetic interactions in long-term regulation of arterial pressure: an hypothesis. Am J Physiol. 1995;268: R1343-R1358.
17. Ferguson AV, Wall KM. Central actions of angiotensin in cardiovascular control: Multiple roles for a single peptide. Can J Physiol Pharmacol. 1992;70:779-785.
18. Ferrari CM, Gildenberg PL, McCubbin JW. Cardiovascular effects of angiotensin mediated by the central nervous system. Circ Res. 1972;30: 257-262.
19. Joy MD, Lowe RD. Evidence that the area postrema mediates the central cardiovascular response to angiotensin II. Nature. 1970;228:1303-1304.
20. Reid IA. Actions of angiotensin II on the brain: mechanisms and physiologic role. Am J Physiol. 1984;246:F533-F543.
21. Simpson JB. The circumventricular organs and the central actions of angiotensin. Neuroendocrinology. 1981;32:248-256.
22. Fink GD, Brimer CA, Mangipane ML. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension. 1987;9:355-361.
23. Hendel MD, Collister JP. Contribution of the subfornical organ to angiotensin II induced hypertension. Am J Physiol Heart Circ Physiol. 2004;999:9-99.
24. Collister JP, Osborn JW. Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats. Am J Physiol. 1998; 274:R357-R366.
25. Hendel MD, Collister JP. Role of the subfornical organ in the chronic hypotensive response to losartan in normal rats. Hypertension. 2003;41: 576-582.
26. Osbom JW, Provo BJ, Montana JS III, et al. Salt-sensitive hypertension caused by long-term α-adrenergic blockade in the rat. Hypertension. 1993;21:995-999.
27. Collister JP, Osborn JW. The chronic infusion of hexamethonium and phenylephrine to effectively clamp the sympathetic nervous system at a fixed level of vasomotor tone: a novel approach. J Pharmacol Toxicol Methods. 1999;42:135-147.
28. Xu L, Collister JP, Osbom JW, et al. Effect of losartan on sympathetic activity and heart rate in sodium deprived rats: role of the area postrema. Am J Physiol. 1998;275:R46-R55.
29. Santajuliana D, Hornfeldt BJ, Osborn JW. Use of ganglionic blockers to assess neurogenic presser activity in conscious rats. J Pharmacol Toxicol Methods. 1996;35:45-54.
30. Chen G, Portman R, Wickel A. Pharmacology of 1,1-dimethyl-4- phenylpiperazinium iodide, a ganglion-stimulating agent. J Pharmacol Exp Ther. 1951;103:330-336.
31. Neter J, Wasserman W. Applied Linear Statistical Models. Homewood, IL: Richard D. Irwin, 1974.
32. Johansson M, Elam M, Rundqvist B, et al. Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension. Hypertension. 2000;36:543-548.
33. Ligtenberg G, Blankestijn PJ, Oey PL, et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med. 1999;340:1321-1328.
34. DiBona GF, Jones SY, Sawin LL. Angiotensin receptor antagonist improves cardiac reflex control of renal sodium handling in heart failure. Am J Physiol. 1998;274:H636-H641.
35. Johns EJ. The role of angiotensin II in the antidiuresis and antinatriuresis induced by stimulation of the sympathetic nerves to the rat kidney. J Auton Pharmacol. 1987;7:205-214.